WebFeb 28, 2024 · SMALL PHARMA INC. Management's Discussion and Analysis This Management's Discussion and Analysis ("MD&A") has been prepared by management of Small Pharma Inc. ("Small Pharma" or the "Company") and should be read in conjunction with Small Pharma's audited consolidated financial statements and notes for the years … WebFeb 15, 2024 · Small Pharma is a biotechnology company researching and developing short-duration psychedelics with therapy for under-served mental health conditions. Corporate …
Small Pharma Reports Fiscal First Quarter 2024 Highlights
WebOct 14, 2024 · Small Pharma is a biotechnology company progressing a pipeline of short-acting psychedelic assisted therapies for the treatment of mental health conditions. The Company’s current focus is on exploring new therapeutic approaches for depression. Small Pharma’s lead candidate, SPL026, is a proprietary synthetic formulation of DMT. WebAug 3, 2024 · Small Pharma is a biotechnology company progressing a pipeline of short-acting psychedelics with therapy for the treatment of mental health conditions, with a current focus on depression. Small Pharma initiated a clinical program into DMT-assisted psychotherapy in February 2024. green light supply chain ltd
ESSA Pharma Announces Clinical Trial Support Agreement with …
WebApr 29, 2024 · A copy of the early warning report providing further details of Mr. Rands’ holdings will be available on the Company’s SEDAR profile at www.sedar.com. A copy of this report can be obtained by contacting Peter Rands, Chief Executive Officer, at +44 (0)2071 129118. About Small Pharma Inc. WebNov 30, 2024 · Small Pharma is advancing a pipeline of DMT-based therapies and is leading the world’s first DMT clinical trial for depression, in collaboration with Imperial College London. For further information contact: Small Pharma Inc. Peter Rands Chief Executive Officer Email: [email protected] Tel: +44 (0)2071 129118 Media Relations Contact WebApr 12, 2024 · About ESSA Pharma Inc. ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma. Forward-Looking Statement Disclaimer flying embers bubbly